Full Year 2024 Melexis NV Earnings Call Transcript
Key Points
- Melexis NV (XBRU:MELE) achieved a record number of product launches in 2024, setting a strong foundation for future sales growth.
- The company continues to capture a strong level of design wins in both automotive and non-automotive applications, indicating robust innovation and market penetration.
- Geographically, Melexis NV has shown strong design win performance in China, confirming strategic positioning in this key market.
- Despite not meeting the original sales target, Melexis NV's 2024 sales were broadly stable and outperformed many peers.
- The company is cautiously optimistic about improving customer demand around summer 2025, based on inventory corrections and market forecasts.
- Melexis NV did not achieve its original sales target of EUR1 billion for 2024, which was a disappointment.
- Sales for the full year 2024 decreased by 3% compared to the previous year, with a notable 21% decrease in Q4 sales year-over-year.
- The operating result for 2024 decreased by 16% compared to 2023, reflecting challenges in maintaining profitability.
- The net result for 2024 saw an 18% decrease compared to the previous year, impacting earnings per share.
- The company is experiencing ongoing customer inventory corrections, which are expected to continue into the first half of 2025, affecting short-term sales outlook.
Hello and welcome to the Melexis quarter four full year, 2024 results. My name is Caroline and I'll be your coordinator for today's event. Please note this call is being recorded. (Operator Instructions) I will now hand over the call to your host, Marc Biron, the CEO to begin today's conference. Thank you.
Thank you for the introduction. Dear audience, thank you for joining the Melexis fourth quarter and full year 2024 earnings call. Together with our CFO, Karen Van Griensven, I will look back on the past year and share how we see the coming year. First, I would like to take a step back and give a bit more perspective on '24.
It has been an unusual year for Melexis with significant contrast in our markets. We have started the year with most of our products still in the location and the other book has reflected good visibility. As the year progressed and the allocation period ended, we thought that we had avoided the bullwhip effect
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
